Why It Matters

Milliken & Co. faces volatile tariff policies, expanding PFAS regulations, and evolving chemical safety standards that threaten its textile and specialty chemical operations. The company is lobbying to shape congressional trade policy uncertainty, defense procurement standards, and chemical regulation modernization—all areas where legislative outcomes could significantly impact manufacturing competitiveness and compliance costs.

Milliken combines in-house advocacy with specialized external firms like Akin Gump Strauss Hauer & Feld LLP and Cross Potomac Consulting LLC to navigate legislative debates from the Protect Our Clothes from PFAS Act to defense textile procurement rules.

By the Numbers

Milliken & Co. spent $190,000 on in-house lobbying in the fourth quarter of 2025, continuing over two decades of federal advocacy. The company has filed 72 in-house disclosures since 2003, totaling $4.75 million in internal lobbying spending.

Current external partners include Akin Gump Strauss Hauer & Feld LLP for high-level legislative work on the NDAA and CHIPS Act, and Cross Potomac Consulting LLC for defense procurement expertise. Milliken’s lobbying historically focuses on trade policy (64 mentions), defense procurement (36 mentions), tariffs (30 mentions), manufacturing incentives (18 mentions), and chemical regulation (18 mentions).

The Agenda

While Milliken & Co. didn’t target specific legislation in the fourth quarter of 2025, the company’s advocacy reveals focus on trade and tariff policy, defense procurement, chemical regulation, and advanced manufacturing incentives.

Several active congressional initiatives align with these priorities, including the bipartisan Better Outfitting Our Troops (BOOTS) Act—which Milliken officially endorsed—and the Protect Our Clothes from PFAS Act targeting PFAS chemicals in textiles. The House Energy and Commerce Committee’s hearing on "Chemicals in Commerce: Modernizing America’s Chemical Safety Law" reflects congressional interest in updating TSCA, central to Milliken’s regulatory landscape.

Broader Context

Congress is actively debating policies directly affecting Milliken’s operations. The proposed Market Choice Act would create a border greenhouse gas adjustment, while Senate committees debate tariffs’ role in manufacturing competitiveness.

The defense textile sector shows bipartisan momentum. The relaunched Congressional Textile Caucus advocates for the U.S. textile industry as a critical military supplier. Chemical regulation is intensifying through House hearings on modernizing TSCA and the bipartisan Protect Our Clothes from PFAS Act, creating both compliance costs and market opportunities.

Between The Lines

Congress is shaping policy across multiple fronts relevant to Milliken’s priorities. On trade, lawmakers debate the Market Choice Act border adjustment mechanism. The bipartisan Congressional Textile Caucus signals strong support for domestic suppliers, while the BOOTS Act ensures American materials in military equipment. Chemical regulation advances through Energy and Commerce Committee hearings on TSCA modernization and PFAS textile restrictions.

Competitive Landscape

Milliken operates within a crowded advocacy ecosystem. The Society of Chemical Manufacturers and Affiliates Inc. (SOCMA) focuses on TSCA implementation and Section 301 tariffs. The National Association of Manufacturers (NAM) covers trade, tariffs, and supply chain issues as one of the sector’s most powerful business lobbies. American Circular Textiles (ACT) and Honeywell International Inc. also overlap with Milliken’s environmental and trade priorities.

The Bottom Line

Milliken & Co. maintains strategic federal advocacy through $190,000 in Q4 2025 in-house lobbying, leveraging specialized external firms to address core priorities across trade policy, defense procurement, and chemical regulation. The company’s endorsement of the BOOTS Act demonstrates direct impact from its lobbying efforts as Congress actively shapes manufacturing and defense policies.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article